Labor Market Pulse · Life Sciences · September 2026
Life Sciences Labor Market Report: Kokomo, IN MSA — September 2026
Kokomo wages surge 10.6% as unemployment climbs on tariff drag.
Kokomo metro earnings grew 10.6% year-over-year through April — fastest in Indiana — even as unemployment held near 5.5%, far above the state's 3.3% rate, complicating cost assumptions for life sciences employers eyeing manufacturing expansion.
Free archive edition. Published by WageScape as sent to subscribers; data as of September 2026.
Key indicators
- Kokomo wage growth: 10.6% — YoY through April 2026, fastest of any Indiana metro
- Kokomo unemployment rate: 5.5% — vs 3.3% Indiana statewide, 4.1% national
- Indiana life sci postings: -31% — YoY through Aug 2026, sharper drop than MA/CA
- Indiana life sci avg. wage: $177,000 — Competitive nationally but below CA/Boston rates
Key takeaways
Kokomo's wage spike is a scarcity signal, not a raise cycle.
10.6% year-over-year earnings growth paired with a 5.5% unemployment rate indicates employers are bidding up pay for a narrowing pool of skilled technical workers, not broadly raising wages amid labor surplus. Compensation benchmarking should separate this from Indiana's statewide 3.8% wage growth average, which understates what specialized roles are actually commanding locally.
Manufacturing concentration cuts both ways for life sciences hiring.
Close to a quarter of Kokomo jobs sit in manufacturing, meaning EV and automotive wage competition directly shapes the going rate for production technicians and quality roles life sciences employers also need. Site selection or expansion decisions should price in this crossover demand rather than relying on generic Indiana manufacturing wage data.
Statewide posting declines mask local execution-critical hiring.
Indiana life sciences postings fell 31% year-over-year through August, yet 170+ open positions persist statewide and national biopharma firms keep recruiting selectively even amid September layoffs. Consider treating posting volume as a weak proxy for actual hiring urgency in CMC, quality, and regulatory functions.
Tariff and policy shocks are reshaping build-vs-outsource math in real time.
EV tax credit removal and tariff uncertainty have visibly dented Howard County's manufacturing employment since April, a reminder that policy volatility can move faster than headcount planning cycles. Build decisions anchored to Indiana's current cost position should stress-test against further federal policy shifts before committing capital.
Median advertised pay by role — Kokomo, IN MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist * | $115,754 | $141,396 | $160,000 | Moderate decline | $131,354 |
| Clinical Research Associate * | $58,351 | $95,900 | $117,775 | Significant increase | $90,956 |
| Lab Technician * | $41,600 | $45,760 | $48,901 | Stable | $47,402 |
| Regulatory Affairs Specialist * | $67,649 | $68,173 | $115,366 | Significant decline | $104,000 |
| Clinical Data Manager * | $95,720 | $122,837 | $140,226 | Significant increase | $123,031 |
| Biostatistician * | $89,157 | $131,328 | $141,301 | Stable | $133,322 |
| Validation Engineer * | $82,654 | $90,028 | $100,298 | Moderate decline | $108,377 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Howard County's manufacturing-heavy labor market remains caught between offsetting forces: StarPlus Energy's $6 billion EV investment continues adding capacity while tariff uncertainty and the lapsed EV tax credit have pushed metro unemployment back up since April, with the rate sitting near 5.5% versus Indiana's statewide 3.3%. Average hourly earnings growth hit 10.6% year-over-year through April 2026, the fastest of any Indiana metro, suggesting employers are paying up for scarce skilled talent even as overall headcount softens.
What it means
Kokomo's wage acceleration amid rising unemployment is a signature of a bifurcated market — general labor supply loosening while specialized technical and quality talent stays scarce and expensive, a dynamic life sciences employers evaluating Indiana manufacturing sites should read carefully before assuming the state's cost advantage holds locally. With Eli Lilly's Lebanon Medicine Foundry and INCOG BioPharma's Fishers expansion both competing statewide for CMC, quality, and production technician talent, Kokomo-area employers may find themselves priced out of the same labor pool despite nominally lower regional wage averages. Organizations should evaluate whether Kokomo's auto-manufacturing wage inflation is beginning to bleed into adjacent technical and quality roles before finalizing site-based compensation benchmarks.
Looking ahead
Worth watching: Whether Howard County unemployment continues climbing as EV tax credit removal and tariff effects work through the automotive supply chain, or stabilizes as StarPlus Energy's second plant ramps toward 2027. A continued rise could loosen the broader technical labor pool life sciences employers draw from.
Emerging pressure point: Statewide competition for CMC and quality talent intensifies as Lilly's Lebanon foundry and INCOG's Fishers expansion both scale hiring through 2026-2027. Watch whether this pulls technical talent out of central Indiana manufacturing hubs, including Kokomo-adjacent labor sheds.
Potential inflection point: National biopharma layoff activity (BioMarin, Bristol Myers) alongside 64% of organizations still actively recruiting suggests a reshuffling rather than a contraction. Released talent from restructuring events may surface in Indiana's candidate pool, particularly for regulatory and quality functions.
Early indicator: Indiana's 31% year-over-year decline in life sciences postings against sustained wage growth in Kokomo's manufacturing sector is worth tracking for signs of cross-industry wage spillover. If technical wage inflation broadens, it could compress the cost advantage driving build decisions into the region.
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.